cyclohexanol has been researched along with Libman-Sacks Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarya, KR; Grover, S; Sharma, A | 1 |
| Dörner, T; Putterman, C | 1 |
2 other study(ies) available for cyclohexanol and Libman-Sacks Disease
| Article | Year |
|---|---|
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Cyclophosphamide; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lupus Erythematosus, Systemic; Olanzapine; Prednisolone; Venlafaxine Hydrochloride | 2013 |
B cells, BAFF/zTNF4, TACI, and systemic lupus erythematosus.
Topics: Animals; B-Cell Activating Factor; B-Lymphocytes; Cyclohexanols; Cyclohexylamines; Humans; Lupus Erythematosus, Systemic; Membrane Proteins; Mice; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2001 |